US 9986723
Screen and use of therapeutics for pancreatic ductal adenocarcinoma
granted A61KA61K31/00A61K31/337
Quick answer
US patent 9986723 (Screen and use of therapeutics for pancreatic ductal adenocarcinoma) held by The Board of Regents of the University of Texas System expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/00, A61K31/337, A61K31/366, A61K31/37